OUTLOOK THERAPEUTICS TARGETS MORE THAN $500M PEAK ANNUAL LYTENAVA SALES BY 2030 AS IT FORECASTS $50M-$75M FIRST-YEAR NET REVENUE - SEEKINGALPHA

$500M peak sales target and $50M-$75M first-year revenue forecast signal significant commercial upside.